N-(Cyclopropylmethyl)-4-iodobenzamide

Catalog No.: 
ACQMTO441
CAS No.: 
39887-31-5
Molecular Formula: 
C11H12INO
Molecular Weight: 
301.13
N-(Cyclopropylmethyl)-4-iodobenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$999.00InquiryInquiry
5g95%$2122.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Cyclopropylmethyl)-4-iodobenzamide
IUPAC NameN-(cyclopropylmethyl)-4-iodobenzamide
MDL No.MFCD14647620
Molecular FormulaC11H12INO
Molecular Weight301.13
SMILESIC1=CC=C(C=C1)C(=O)NCC1CC1
InChI KeyWKGKELXHCISANA-UHFFFAOYSA-N
SynonymN-(Cyclopropylmethyl)-4-iodobenzamide;Benzamide, N-(cyclopropylmethyl)-4-iodo-
CAS No.39887-31-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACQMTO441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKYTW152 route compound structure diagram
    ACKYTW1522516-47-4In Stock
  2. Plus
  3. ACBLYH147 route compound structure diagram
    ACBLYH147619-58-9In Stock
  4. Then
  5. ACQMTO441 route product structure diagram
    ACQMTO44139887-31-5
Inquiry

2. ACQMTO441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKYTW152 route compound structure diagram
    ACKYTW1522516-47-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQMTO441 route product structure diagram
    ACQMTO44139887-31-5
Inquiry

3. ACQMTO441 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYCRV452 route compound structure diagram
    ACYCRV452619-44-3In Stock
  2. Plus
  3. ACKYTW152 route compound structure diagram
    ACKYTW1522516-47-4In Stock
  4. Then
  5. ACQMTO441 route product structure diagram
    ACQMTO44139887-31-5
Inquiry

Comments (0)